Association of metformin with risk of digestive tract cancers from a drug target mendelian randomization and cell experiments
Metformin may be used for the prevention or treatment of liver and bile duct cancers.
Authors
- Xirong Cao
- Yifan Jia (ORCID: https://orcid.org/0000-0002-3420-2239)
- Chang Liu (ORCID: https://orcid.org/0000-0002-7033-9478)
- Yifei Wang (ORCID: https://orcid.org/0000-0002-8873-613X)
- Xing Zhang (ORCID: https://orcid.org/0000-0001-7101-7182)
- Rui Chen (ORCID: https://orcid.org/0000-0002-2884-9896)
- Jie Ren (ORCID: https://orcid.org/0000-0002-6450-3163)
- Ting Lin (ORCID: https://orcid.org/0000-0002-7383-7130)
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1007/s12672-025-02729-3
- Citations
- 1
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81